BIFERA
Alaven Pharmaceutical LLC
| Research |
OneLook
Acronym Finder
|
| Serial Number | 77779124 |
| Registration Number | 3725580 |
| Mark Drawing Code | 5000: Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form |
| Cancellation Code | 2 |
| Attorney Name | Ashish D. Patel |
| Attorney Docket Number | 076517-032US |
| Law Office Assigned | L80 |
| Employee Name | SAPP, HEATHER AMANDA |
Timeline
| 2009-03-12 | Date of First Use |
| 2009-07-12 | Application Filed |
| 2009-09-29 | Published for Opposition |
| 2009-12-15 | Location: PUBLICATION AND ISSUE SECTION |
| 2009-12-15 | Trademark Registered |
| 2016-07-22 | Cancelled |
| 2016-07-22 | Status: Dead/Cancelled |
| 2018-07-08 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  Alaven Pharmaceutical LLC |
| Address | Suite 428 200 North Cobb Parkway Marietta DE 30062 |
| Legal Entity Type | Limited Liability Company |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| CC0000 | The color(s) purple is/are claimed as a feature of the mark. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| NEW APPLICATION ENTERED IN TRAM | 2009-07-15 | 1 NWAP I:Incoming Correspondence |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2009-07-15 | 2 NWOS I:Incoming Correspondence |
| ASSIGNED TO EXAMINER | 2009-08-18 | 3 DOCK D:Assigned to Examiner |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2009-08-18 | 4 CNSA O:Outgoing Correspondence |
| ASSIGNED TO LIE | 2009-08-24 | 5 ALIE A:Allowance for Publication |
| LAW OFFICE PUBLICATION REVIEW COMPLETED | 2009-08-24 | 6 PREV O:Outgoing Correspondence |
| NOTICE OF PUBLICATION | 2009-09-09 | 7 NPUB O:Outgoing Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2009-09-16 | 8 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2009-09-16 | 9 ARAA I:Incoming Correspondence |
| PUBLISHED FOR OPPOSITION | 2009-09-29 | 10 PUBO A:Allowance for Publication |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2009-10-21 | 11 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2009-10-28 | 12 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2009-11-25 | 13 ASCK I:Incoming Correspondence |
| ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2009-12-02 | 14 ASCK I:Incoming Correspondence |
| REGISTERED-PRINCIPAL REGISTER | 2009-12-15 | 15 R.PR A:Allowance for Publication |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2014-09-04 | 16 TCCA I:Incoming Correspondence |
| CANCELLED SEC. 8 (6-YR) | 2016-07-22 | 17 C8.. O:Outgoing Correspondence |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 BIFERA 77779124 3725580 Dead/Cancelled |
Alaven Pharmaceutical LLC 2009-07-12 |
 BIFERA 77779121 3725579 Dead/Cancelled |
Alaven Pharmaceutical LLC 2009-07-12 |
 BIFERA 77394597 3661656 Live/Registered |
Alaven Pharmaceutical LLC 2008-02-12 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 